Rostami et al. observed reductions in inflammatory cytokines and OS in women with endometriosis following ASX use, and a meta-analysis of 14 clinical trials confirmed the efficacy of ASX in lowering CRP levels (Rostami et al., 2023; Xia et al., 2020). The gene discussed is CRP; the disease is endometriosis.